ARIX Arix Bioscience Plc

Arix Bioscience PLC (ARIX) 
Holding(s) in Company 
17-Jul-2023 / 15:00 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
TR-1: Standard form for notification of major holdings 
1. Issuer Details 
ISIN 
GB00BD045071 
Issuer Name 
ARIX BIOSCIENCE PLC 
UK or Non-UK Issuer 
UK 
2. Reason for Notification 
An acquisition or disposal of voting rights 
3. Details of person subject to the notification obligation 
Name 
Ruffer LLP 
City of registered office (if applicable) 
London 
Country of registered office (if applicable) 
United Kingdom 
4. Details of the shareholder 
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above 
 
City of registered office (if applicable) 
 
Country of registered office (if applicable) 
 
5. Date on which the threshold was crossed or reached 
14-Jul-2023 
6. Date on which Issuer notified 
17-Jul-2023 
7. Total positions of person(s) subject to the notification obligation 
                                % of voting rights     % of voting rights through      Total of both Total number of 
.                               attached to shares     financial instruments (total of in % (8.A +   voting rights held 
                                (total of 8.A)         8.B 1 + 8.B 2)                  8.B)          in issuer 
Resulting situation on the date 
on which threshold was crossed  4.977220               0.000000                        4.977220      6440000 
or reached 
Position of previous 
notification (if applicable) 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN Number of direct voting Number of indirect voting % of direct voting   % of indirect voting 
code(if possible)         rights (DTR5.1)         rights (DTR5.2.1)         rights (DTR5.1)      rights (DTR5.2.1) 
GB00BD045071              6440000                 0                         4.977220             0.000000 
Sub Total 8.A             6440000                                           4.977220% 

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial   Expiration Exercise/         Number of voting rights that may be acquired if the       % of voting 
instrument          date       conversion period instrument is exercised/converted                         rights 
 
Sub Total 8.B1 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial       Expiration    Exercise/conversion    Physical or cash       Number of voting    % of voting 
instrument              date          period                 settlement             rights              rights 
 
Sub Total 8.B2 

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate      Name of     % of voting rights if it    % of voting rights through financial   Total of both if it equals 
controlling   controlled  equals or is higher than    instruments if it equals or is higher  or is higher than the 
person        undertaking the notifiable threshold    than the notifiable threshold          notifiable threshold 
 

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Ruffer LLP now controls the voting rights over 6,440,000 shares (less than 5% of the voting rights) of Arix Bioscience plc which are held by the discretionary clients of Ruffer LLP and its subsidiaries (the voting of which is all controlled by Ruffer LLP). This change from 5% to less than 5% is due to the sale of 80,000 shares by Ruffer LLP on 14 July 2023.

12. Date of Completion

17-Jul-2023

13. Place Of Completion

Ruffer LLP

----------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

ISIN:           GB00BD045071 
Category Code:  HOL 
TIDM:           ARIX 
LEI Code:       213800OVT3AHQCXNIX43 
OAM Categories: 2.3. Major shareholding notifications 
Sequence No.:   258222 
EQS News ID:    1681769 
 
End of Announcement  EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1681769&application_name=news

(END) Dow Jones Newswires

July 17, 2023 10:00 ET (14:00 GMT)

Arix Bioscience (LSE:ARIX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

Arix Bioscience (LSE:ARIX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025